Sign inGet started

Sarissa Capital Catapult Fund LLC

Insider CIK 1716725 · RGLS 10% owner · ITRM 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ITRM Iterum Therapeutics plc S Sale2021-02-122021-02-1210,619,949$2.27 $24.11M0SEC↗
ITRM Iterum Therapeutics plc C Conversion deriv2021-02-112021-02-1215,000,000— $00SEC↗
ITRM Iterum Therapeutics plc S Sale2021-02-112021-02-1210,000,000$2.59 $25.90M10,619,949SEC↗
ITRM Iterum Therapeutics plc C Conversion2021-02-112021-02-1220,619,949— $020,616,949SEC↗
RGLS Regulus Therapeutics Inc. P Buy deriv2019-12-242020-01-03423,162— $0423,162SEC↗
RGLS Regulus Therapeutics Inc. P Buy deriv2019-12-242020-01-034,231,620— $06,083,471SEC↗